Senate spending bill slashes funds for Biden's planned breakthrough drug accelerator at NIH
With the announcement that Francis Collins, the NIH’s longtime head, is leaving at the end of the year, a flashy new idea from President Joe Biden to accelerate more cancer, diabetes and Alzheimer’s drugs at the NIH appears to have lost steam.
The Senate Appropriations Committee on Monday unveiled its proposal for the NIH’s spending bill, which proposes just $2.4 billion for this Biden project, to be known as the Advanced Research Projects Agency for Health or ARPA-H. Biden had initially requested $6.5 billion, and the House Appropriations Committee signed off on $3 billion earlier this summer.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.